Hunter syndrome drug hunterase passes Long-Term safety check in 30 patients
NCT ID NCT07344376
First seen Jan 26, 2026 · Last updated May 22, 2026 · Updated 18 times
Summary
This study looked at the long-term safety of Hunterase, a drug for Hunter syndrome, in 30 patients who had already completed a previous study or used the drug for over 6 months. The main goal was to check for side effects and changes in lab tests, physical exams, and heart activity. The study did not aim to cure the disease but to ensure the drug remains safe for ongoing use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUNTER SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Samsung Medical Center
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.